K.AhujaV.SingalD.GoswamiP.et al (2009)
R., Baber, R., Panay, N., Bitzer, J., Perez, S
These medicines mimic the natural hormone but remain active for longer periods, helping with blood sugar management in type 2 diabetes 1
When patients stopped semaglutide in controlled research settings, they regained roughly two-thirds of their lost weight within a year
While clinical evidence is still emerging, GLP-1s potential dual ability to reduce the risk of comorbidities and stabilize patients with fewer additional drugs positions them as a cornerstone of modern diabetes care
Despite this distinction, both medications offer similar benefits in weight loss, with clinical studies showing significant weight reduction, particularly with Wegovy